U.S. Anti-Venom Market (2025 - 2030) Size, Share & Trends Analysis Report By Species (Snake, Scorpion, Spider), By Type (Polyvalent, Monovalent), By Mode of Action (Cytotoxic, Neurotoxic), By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Species
                       1.2.2. Type
                       1.2.3. Mode of action
                       1.2.4. End use
                       1.2.5. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market formulation & Validation
                   1.7. Model Details
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Species outlook
                       2.2.2. Type outlook
                       2.2.3. Mode of action outlook
                       2.2.4. End use outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Anti-Venom Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                       3.2.2. Market restraint analysis
                   3.3. U.S. Anti-Venom Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
                   3.4. U.S. Anti-Venom Market: Pipeline Analysis
Chapter 4. U.S. Anti-Venom Market: Species Estimates & Trend Analysis
                   4.1. Species Segment Dashboard
                   4.2. U.S. Anti-Venom Market: Species Movement Analysis
                   4.3. U.S. Anti-Venom Market Size & Trend Analysis, by Species, 2018 to 2030 (USD Million)
                   4.4. Snake
                       4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.2. Common Cobra
                           4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.3. Common Krait
                           4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.4. Russell Viper
                           4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.5. Others
                           4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.5. Scorpion
                       4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.6. Spider
                       4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.7. Other
                       4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Anti-Venom Market: Type Estimates & Trend Analysis
                   5.1. Type Segment Dashboard
                   5.2. U.S. Anti-Venom Market: Type Movement Analysis
                   5.3. U.S. Anti-Venom Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                   5.4. Polyvalent
                       5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.5. Monovalent
                       5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Anti-Venom Market: Mode of Action Estimates & Trend Analysis
                   6.1. Mode of Action Segment Dashboard
                   6.2. U.S. Anti-Venom Market: Mode of Action Movement Analysis
                   6.3. U.S. Anti-Venom Market Size & Trend Analysis, by Mode of Action, 2018 to 2030 (USD Million)
                   6.4. Cytotoxic
                       6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.5. Neurotoxic
                       6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.6. Hemotoxic
                       6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.7. Cardiotoxic
                       6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.8. Myotoxic
                       6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.9. Others
                       6.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Anti-Venom Market: End Use Estimates & Trend Analysis
                   7.1. End Use Segment Dashboard
                   7.2. U.S. Anti-Venom Market: End Use Movement Analysis
                   7.3. U.S. Anti-Venom Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                   7.4. Hospitals
                       7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.5. Clinics
                       7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.6. Ambulatory Surgical Centers
                       7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                   8.3. Vendor Landscape
                       8.3.1. Key company heat map analysis, 2024
                   8.4. Company Profiles
                       8.4.1. Boehringer Ingelheim
                           8.4.1.1. Company overview
                           8.4.1.2. Financial performance
                           8.4.1.3. Product benchmarking
                           8.4.1.4. Strategic initiatives
                       8.4.2. CSL Limited
                           8.4.2.1. Company overview
                           8.4.2.2. Financial performance
                           8.4.2.3. Product benchmarking
                           8.4.2.4. Strategic initiatives
                       8.4.3. Merck & Co., Inc.
                           8.4.3.1. Company overview
                           8.4.3.2. Financial performance
                           8.4.3.3. Product benchmarking
                           8.4.3.4. Strategic initiatives
                       8.4.4. Pfizer, Inc.
                           8.4.4.1. Company overview
                           8.4.4.2. Financial performance
                           8.4.4.3. Product benchmarking
                           8.4.4.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. anti-venom market, by species, 2018 - 2030 (USD Million)
Table 3 U.S. anti-venom market, by snake 2018 - 2030 (USD Million)
Table 4 U.S. anti-venom market, by type 2018 - 2030 (USD Million)
Table 5 U.S. anti-venom market, by mode of action 2018 - 2030 (USD Million)
Table 6 U.S. anti-venom market, by end use 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. anti-venom market: market outlook
Fig. 10 U.S. anti-venom competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. anti-venom market driver impact
Fig. 16 U.S. anti-venom market restraint impact
Fig. 17 U.S. anti-venom market strategic initiatives analysis
Fig. 18 U.S. anti-venom market: Species movement analysis
Fig. 19 U.S. anti-venom market: Species outlook and key takeaways
Fig. 20 Snake market estimates and forecasts, 2018 - 2030
Fig. 21 Common cobra market estimates and forecasts, 2018 - 2030
Fig. 22 Common krait market estimates and forecasts, 2018 - 2030
Fig. 23 Russell viper market estimates and forecasts, 2018 - 2030
Fig. 24 Others market estimates and forecasts, 2018 - 2030
Fig. 25 Scorpion market estimates and forecasts, 2018 - 2030
Fig. 26 Spider market estimates and forecasts, 2018 - 2030
Fig. 27 Other market estimates and forecasts, 2018 - 2030
Fig. 28 U.S. anti-venom market: Type movement analysis
Fig. 29 U.S. anti-venom market: Type outlook and key takeaways
Fig. 30 Polyvalent market estimates and forecasts, 2018 - 2030
Fig. 31 Monovalent market estimates and forecasts, 2018 - 2030
Fig. 32 U.S. anti-venom market: Mode of Action movement analysis
Fig. 33 U.S. anti-venom market: Mode of Action outlook and key takeaways
Fig. 34 Cytotoxic market estimates and forecasts, 2018 - 2030
Fig. 35 Neurotoxic market estimates and forecasts, 2018 - 2030
Fig. 36 Hemotoxic market estimates and forecasts, 2018 - 2030
Fig. 37 Cardiotoxic market estimates and forecasts, 2018 - 2030
Fig. 38 Myotoxic market estimates and forecasts, 2018 - 2030
Fig. 39 Others market estimates and forecasts, 2018 - 2030
Fig. 40 U.S. anti-venom market: End Use movement analysis
Fig. 41 U.S. anti-venom market: End Use outlook and key takeaways
Fig. 42 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 43 Clinics market estimates and forecasts, 2018 - 2030
Fig. 44 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030